- Home
- MATX vs AAPG Comparison
MATX vs AAPG Comparison
Compare MATX & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MATX
- AAPG
- Stock Information
- Founded
- MATX 1882
- AAPG 2009
- Country
- MATX United States
- AAPG China
- Employees
- MATX N/A
- AAPG N/A
- Industry
- MATX Marine Transportation
- AAPG Biotechnology: Pharmaceutical Preparations
- Sector
- MATX Consumer Discretionary
- AAPG Health Care
- Exchange
- MATX Nasdaq
- AAPG Nasdaq
- Market Cap
- MATX 3.1B
- AAPG 3.6B
- IPO Year
- MATX N/A
- AAPG 2025
- Fundamental
- Price
- MATX $97.71
- AAPG $33.50
- Analyst Decision
- MATX Hold
- AAPG Buy
- Analyst Count
- MATX 4
- AAPG 1
- Target Price
- MATX $131.67
- AAPG N/A
- AVG Volume (30 Days)
- MATX 336.0K
- AAPG 7.7K
- Earning Date
- MATX 11-04-2025
- AAPG 11-19-2025
- Dividend Yield
- MATX 1.47%
- AAPG N/A
- EPS Growth
- MATX 56.13
- AAPG N/A
- EPS
- MATX 14.81
- AAPG N/A
- Revenue
- MATX $3,464,800,000.00
- AAPG $54,524,554.00
- Revenue This Year
- MATX N/A
- AAPG N/A
- Revenue Next Year
- MATX $1.45
- AAPG $368.64
- P/E Ratio
- MATX $6.60
- AAPG N/A
- Revenue Growth
- MATX 8.75
- AAPG N/A
- 52 Week Low
- MATX $86.97
- AAPG $16.50
- 52 Week High
- MATX $169.12
- AAPG $48.45
- Technical
- Relative Strength Index (RSI)
- MATX 51.38
- AAPG 35.64
- Support Level
- MATX $92.64
- AAPG $33.12
- Resistance Level
- MATX $95.60
- AAPG $35.07
- Average True Range (ATR)
- MATX 2.68
- AAPG 1.05
- MACD
- MATX 0.73
- AAPG -0.16
- Stochastic Oscillator
- MATX 77.88
- AAPG 8.96
About MATX Matson Inc.
Matson Inc is engaged in providing ocean transportation and logistics services. The business segments of the company are Ocean Transportation which provides ocean freight transportation services to the domestic non-contiguous economies of Hawaii, Alaska, California, Okinawa, and different islands in the South Pacific, and Logistics segment which offers long haul and regional highway trucking services, warehousing and distribution services, supply chain management, and freight forwarding services. The firm generates the majority of its revenue from the Ocean Transportation segment.
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.